Applied DNA Sciences Seeks To Expand Approved Use Of Linea Mpox Virus 1.0 Assay For Detection Of Mpox Clade I Following WHO's Public Health Emergency Declaration, With Validation Studies Underway For NYSDOH Filing
Portfolio Pulse from Benzinga Newsdesk
Applied DNA Sciences is working to expand the use of its Linea Mpox Virus 1.0 Assay for detecting Mpox Clade I, following the WHO's public health emergency declaration. Validation studies are in progress for a filing with the NYSDOH.
August 19, 2024 | 7:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Applied DNA Sciences is seeking to expand the use of its Linea Mpox Virus 1.0 Assay to include detection of Mpox Clade I, following a WHO emergency declaration. This could enhance the company's market position in virus detection.
The expansion of the assay's use could lead to increased demand and revenue for APDN, especially given the WHO's emergency declaration. The ongoing validation studies for NYSDOH filing indicate a serious commitment to regulatory compliance, which is crucial for market approval and adoption.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100